Today, Invent Medic publishes the first issue of the company’s newsletter aimed at shareholders, investors and other interested parties.

This issue highlights that Invent Medics first product Efemia Bladder Support was included in several marketing campaigns by the two largest pharmacy chains in Sweden (Apoteket AB and Apotek Hjärtat) during the spring, and that the company is now stepping up its efforts to establish the product also in Europe outside of the Nordic region. Additionally, the newsletter includes an article on the positive results received from a new follow-up study with Efemia conducted together with a training center for women.

To read the newsletter, and subscribe to receive upcoming issues, follow this link:

The newsletter is published in Swedish and English, with a flexible publishing frequency based on Invent Medic’s news flow. It is produced together with the company’s IR communication partner Honeybadger, Invent Medic encourages feedback and requests on topics for upcoming issues of the newsletter.

Download: Release